The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
The factors shaping the healthcare landscape in emerging markets.
Novo expects Victoza and semaglutide to gain momentum.
An innovative programme is being rolled out across Kenya.
Japanese firm has set money aside for emerging markets M&A.
Impact of putting access to medicine at the core of pharma businesses.
Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
Actions of Chinese subsidiaries violated US bribery laws, says SEC.
